Maravai LifeSciences  Inc. logo

Maravai LifeSciences Inc.

MRVI | NASDAQ
Chart Builder DCF Calculator
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-130.77M -259.62M -119.03M 490.66M 469.25M 78.82M
Depreciation & Amortization
60.47M 56.87M 48.78M 38.1M 24.75M 25.84M
Stock-Based Compensation
n/a 49.42M 34.59M 18.67M 10.46M 24.63M
Other Working Capital
-21.45M -28.07M 7.52M -30.69M -85.34M 86.96M
Other Non-Cash Items
20.73M 171.1M -690.9M -8.7M -6.16M -7.52M
Deferred Income Tax
-20K 2.32M 754.94M 42.32M 46.9M -5.46M
Change in Working Capital
-7.98M -12.61M 97.84M -45.08M -176.63M 35.89M
Operating Cash Flow
-57.57M 7.47M 126.22M 535.98M 368.57M 152.19M
Capital Expenditures
-13.15M -29.66M -65.55M -17.09M -14.85M -25.41M
Cash Acquisitions
-18.26M n/a -69.62M -238.35M 119.96M -3.02M
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a 5.34M 12.87M -12.17M 548K 34.5M
Investing Cash Flow
-31.41M -24.32M -122.31M -267.61M 105.66M 6.07M
Debt Repayment
-5.44M -234.07M -5.77M -5.44M -6M 196.92M
Common Stock Repurchased
n/a -2.08M -20K n/a n/a -1.46B
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-11.06M 443K -55.3M -184.42M -154.76M -100.91M
Financial Cash Flow
-16.5M -235.71M -61.09M -187.5M -159.05M 53.21M
Net Cash Flow
-105.51M -252.56M -57.18M 80.87M 315.09M 211.48M
Free Cash Flow
-70.72M -22.19M 60.67M 518.89M 353.72M 126.78M
Adj. Free Cash Flow
-70.72M -71.61M 26.08M 500.22M 343.26M 102.15M
Maintenance CapEx
-13.15M -29.66M -65.55M -204.62K n/a n/a
Growth CapEx
n/a n/a n/a -16.89M -14.85M -25.41M
Owner Earnings
-70.72M -22.19M 60.67M 535.77M 368.57M 152.19M

© 2026 bestshares.com. All rights reserved.